AFINITOR Reviews (EVEROLIMUS)

Average Rating: 3.0 (3 Ratings)

Filter Results

Compare AFINITOR with similar:

 Type: Rx Drug

  

AFINITOR  (EVEROLIMUS):  Everolimus is used to treat various types of cancer (such as kidney, breast, pancreas, lung, stomach/intestinal cancers). Everolimus is also used in people with a certain genetic disorder (tuberous sclerosis complex) to treat certain types of benign tumors in the brain or kidney. It works by slowing or stopping the growth of cancer or tumor cells.   FDA Approval Date: 2009-03-30 (Sources: U.S. Centers for Medicare Services, FDA)

  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR AFINITORCOMMENTSSEXAGEDURATION/
DOSAGE
DATE ADDED
 
 5  Breast cancer Tiredness that got better . Edema in ankles after several years . Hair thinning.Joint pain After 5 years on Afinitor doctor said I should consider going off of drug. It can cause high blood sugar and high cholesterol . I had neither of those but opted to go off. 7 months off only monthly hormone injection and cancer still stable. F 66 5 years
10mg 1X day
11/16/2020
 1  Metastatic breast cancer Palpitations, elevated blood glucose, leg pain, headache, nose bleeds This drug needs to be off the market. There are too many side effects. One of the main ones, rising glucose levels have thrown patients into Diabetes. F 62 3 months
5 mg 1X day
1/24/2018
 3  stage 4 breast cancer 1s Mouth dotes F 67 1 months
10 mg
2/8/2013
  

AFINITOR  (EVEROLIMUS):  Everolimus is used to treat various types of cancer (such as kidney, breast, pancreas, lung, stomach/intestinal cancers). Everolimus is also used in people with a certain genetic disorder (tuberous sclerosis complex) to treat certain types of benign tumors in the brain or kidney. It works by slowing or stopping the growth of cancer or tumor cells.   FDA Approval Date: 2009-03-30 (Sources: U.S. Centers for Medicare Services, FDA)

     

BACK TO TOP